Proprotein convertase subtilisin/kexin type 1 (PCSK1) [PDF]
openaire +1 more source
A feasibility study on predicting disease progression in high-grade gliomas using magnetic resonance imaging habitat radiomics based on response assessment in neuro-oncology (RANO) criteria. [PDF]
Zhu Y +12 more
europepmc +1 more source
Dramatic Coronary Artery Aneurysm Regression After Coronary Artery Bypass Grafting and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy. [PDF]
Yokoyama Y +3 more
europepmc +1 more source
Non-antibody Approaches to Proprotein Convertase Subtilisin Kexin 9 Inhibition: siRNA, Antisense Oligonucleotides, Adnectins, Vaccination, and New Attempts at Small-Molecule Inhibitors Based on New Discoveries [PDF]
Toshiyuki Nishikido, Kausik K. Ray
openalex +1 more source
ASSOCIATION OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 WITH HYPERTENSION AND SMOKING
K. S. Benimetskaya +6 more
openalex +1 more source
Erratum to: Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia [PDF]
Nicola Ferri, Massimiliano Ruscica
openalex +1 more source
Retraction: Poor condyle position after mandibular reconstruction and a classification system for patients with "VSCU" based on computed tomography: a cross-sectional study with retrospective data collection. [PDF]
Wang K, He Z, Yang X, Shang W, Wang L.
europepmc +1 more source
Advances in Beyond Statin Lipid Therapies for ASCVD Risk Reduction. [PDF]
Shimabukuro M.
europepmc +1 more source
Imaging-based transformer model predicts early therapy response in advanced nasopharyngeal carcinoma: a dual-center study. [PDF]
Shi K +9 more
europepmc +1 more source

